Kobayashi Pharmaceutical Co. Ltd.
http://www.kobayashi.co.jp
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Kobayashi Pharmaceutical Co. Ltd.
Clinical Trials Recommended For Pamprin Botanicals PMS Claims After Challenge By Bayer
Focus Consumer Healthcare appeals NAD recommendation to pull or modify majority of express and implied claims on Pamprin Botanical product packaging, in advertising and Amazon listings challenged by Bayer Consumer.
Pediatric Promise: China Bets On Better Medicines Amid Three Child Policy Roll-Out
As China's regulators renew moves to encourage the development of pediatric medicines, indication expansion may give health players a new growth engine, despite remaining policy challenges and lingering market uncertainties.
Japan's Kobayashi Acquires Alva-Amco To Expand In US
By acquiring Illinois' Alva-Amco, Japan's Kobayashi is hoping to take its US consumer business, and brands such as Zim's Max, to the next level.
Medical Device Deals Update, November 2015
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced September-October 2015.
Company Information
- Industry
- Medical Devices
- Pharmaceuticals
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice